…Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and is close…
MASLD
This disease is selected. Its supporting articles are shown below.
Articles mentioning MASLD
77 articles · page 4 of 7…s.Methods We used UK Biobank data to determine whether incident CVD (the exposure; coronary heart disease [CHD], myocardial infarct…
…al feasibility of non-invasive diagnostic indicators across the NAFLD, MAFLD and MASLD diagnostic criteria.Design Cross-sectional stu…
…so be involved. Weight loss with lifestyle interventions, early CRC screening, bariatric surgery and use of GLP-1 receptor agonists…
…Fs. Therefore, MASLD’s role may warrant consideration in future heart failure risk stratification.…
…Background and study aim Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common metabolic and liver condition that leads to systemi…
…commend HCC surveillance in patients with cirrhosis when annual HCC incidence exceeds 1% without specifying the role of non-invasiv…
…Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) presents considerable variability in disease progressio…
…iral hepatitis 2 (3%), Drug-induced liver injury (DILI) 1 (2%), Hereditary haemochromatosis (HH) 1 (2%) and other 5 (8%). Severity of CLD included Cirrhosi…
…Background Obesity is a growing global epidemic affecting over one billion people.…
…were observed in the analysis of MALO.Conclusions Patients with type 2 diabetes who had more controlled risk factors showed progressively lower…
…unction-associated steatotic liver disease (MASLD), obesity and type 2 diabetes mellitus (T2DM) are interconnected global epidemics that frequently coexist and…